How to Help Your Patients Save Money on Pentasa XR: A Provider's Guide to Savings Programs

Medication cost is one of the most commonly cited reasons for non-adherence in patients with ulcerative colitis. Pentasa XR (mesalamine extended-release) can cost over $800 per month at retail without insurance coverage, and even with insurance, brand-name copays can be prohibitively high. As a prescriber or care coordinator, understanding the savings options available can directly improve your patients' adherence to their UC treatment regimen — and their clinical outcomes.

This guide covers the most effective cost-reduction strategies for Pentasa XR and its generic equivalent, mesalamine ER — including manufacturer programs, formulary strategies, generic substitution, and discount card resources.

Understanding Pentasa XR Pricing for Your Patients

Before recommending a savings strategy, it helps to understand the pricing landscape:

• Brand Pentasa (retail): $800–$1,200/month for 120 capsules at 500 mg
• Brand Pentasa with GoodRx coupon: As low as ~$209 (74% savings off retail)
• Generic mesalamine ER with GoodRx coupon: As low as ~$43 — a 95% savings off retail for some formulations
• Insurance (generic, Tier 1–2): $10–$40 copay; brand may require Tier 3–4 or non-preferred copay of $60–$150+

Strategy 1: Prescribe Generic Mesalamine ER When Clinically Appropriate

The most impactful single action for most UC patients is switching from brand Pentasa to generic mesalamine ER capsules. The FDA has approved generic mesalamine ER as bioequivalent. Most commercial and Medicare Part D formularies place the generic at Tier 1–2 while placing brand at Tier 3–4.

Clinical consideration: As of early 2026, the 500 mg generic is on back order from Sun Pharma. Patients who need the generic may need to use the 250 mg strength (four capsules per dose rather than two). Make sure the prescription accounts for this and document in the chart.

Strategy 2: Guide Patients to Prescription Discount Cards

Many patients — especially those with high-deductible plans or who are uninsured — benefit dramatically from prescription discount cards. As a provider, you can include information about these resources in your after-visit summary or discharge instructions:

• GoodRx: Free app and website; shows mesalamine ER prices at nearby pharmacies. Generic as low as ~$43; brand as low as ~$209 with coupons.
• SingleCare: Comparable discounts; worth comparing at specific pharmacies.
• NeedyMeds: Provides both manufacturer patient assistance and discount card resources in one place.

Important: These cards cannot be combined with insurance. However, for patients whose out-of-pocket cost with insurance exceeds the cash discount card price (common with high-deductible plans), the discount card is the better choice.

Strategy 3: Refer Patients to Takeda's Patient Assistance Program

Takeda Pharmaceuticals, the maker of brand-name Pentasa, has patient assistance programs for qualifying uninsured and underinsured patients. Eligibility is income-based. Your practice's social worker, financial counselor, or a dedicated enrollment coordinator can help patients apply. Alternatively, Takeda's medical information team or the Takeda Assistance Program website can be contacted directly.

Documentation tip: Patient assistance applications typically require a provider signature confirming the medical necessity of the medication. Streamline your workflow by designating a staff member to manage these applications and keep a template letter on file.

Strategy 4: Use Formulary Exception and Prior Authorization to Lower Brand Copays

For patients on insurance where brand Pentasa is at a high tier, consider submitting a formulary exception request for a lower tier placement. Key justifications include:

• Active shortage of generic mesalamine ER (document with ASHP shortage bulletin reference)
• Clinical need for the specific release profile of Pentasa XR (for patients with small bowel disease)
• Documented prior failure or intolerance to preferred tier alternatives

Strategy 5: Recommend 90-Day Supplies and Mail Order

Encourage patients with stable disease to request a 90-day supply via mail order. Most insurance plans charge a lower per-dose copay for 90-day fills than for three separate 30-day fills. Mail-order pharmacies also serve as a separate inventory pool from retail — which may be valuable during the current shortage.

Strategy 6: Consider Cost-Effective Therapeutic Alternatives

When cost is a primary barrier and the patient has colon-only UC with no special clinical reason to require Pentasa XR's pan-GI release profile, prescribing a lower-cost mesalamine alternative may be clinically appropriate and dramatically reduce the patient's financial burden:

• Generic Lialda (mesalamine 1.2 g DR): As low as ~$140/month with discount card; Tier 1–2 on most plans
• Sulfasalazine (generic): One of the least expensive UC options; often under $30/month. Appropriate for sulfa-tolerant patients without contraindications.

How medfinder Can Support Cost-Conscious Patients

When patients are on a tight budget, finding the lowest-cost pharmacy that has the medication in stock matters more than ever. medfinder.com helps patients identify pharmacies in their area that have their prescription available, so they aren't wasting time and transportation costs driving to pharmacies that are out of stock. For the full patient-facing savings guide, see: How to save money on Pentasa XR in 2026